Drug Resistance, Microbial
"Drug Resistance, Microbial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
Concept/Terms
Drug Resistance, Microbial- Drug Resistance, Microbial
- Drug Resistances, Microbial
- Antimicrobial Drug Resistance
- Antimicrobial Drug Resistances
Below are MeSH descriptors whose meaning is more general than "Drug Resistance, Microbial".
Below are MeSH descriptors whose meaning is more specific than "Drug Resistance, Microbial".
This graph shows the total number of publications written about "Drug Resistance, Microbial" by people in Harvard Catalyst Profiles by year, and whether "Drug Resistance, Microbial" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 3 | 25 | 28 |
| 1994 | 4 | 12 | 16 |
| 1995 | 4 | 15 | 19 |
| 1996 | 7 | 35 | 42 |
| 1997 | 14 | 21 | 35 |
| 1998 | 6 | 36 | 42 |
| 1999 | 7 | 33 | 40 |
| 2000 | 7 | 34 | 41 |
| 2001 | 8 | 25 | 33 |
| 2002 | 4 | 7 | 11 |
| 2003 | 2 | 5 | 7 |
| 2004 | 0 | 4 | 4 |
| 2005 | 2 | 4 | 6 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 6 | 8 |
| 2008 | 6 | 1 | 7 |
| 2009 | 2 | 5 | 7 |
| 2010 | 3 | 1 | 4 |
| 2011 | 6 | 5 | 11 |
| 2013 | 8 | 5 | 13 |
| 2014 | 12 | 8 | 20 |
| 2015 | 9 | 3 | 12 |
| 2016 | 3 | 5 | 8 |
| 2017 | 2 | 7 | 9 |
| 2018 | 8 | 5 | 13 |
| 2019 | 9 | 7 | 16 |
| 2020 | 7 | 7 | 14 |
| 2021 | 4 | 7 | 11 |
| 2022 | 0 | 5 | 5 |
| 2023 | 0 | 1 | 1 |
Below are the most recent publications written about "Drug Resistance, Microbial" by people in Profiles.
-
CanB is a metabolic mediator of antibiotic resistance in Neisseria gonorrhoeae. Nat Microbiol. 2023 Jan; 8(1):28-39.
-
Antibiotic resistance genes in the gut microbiota of mothers and linked neonates with or without sepsis from low- and middle-income countries. Nat Microbiol. 2022 09; 7(9):1337-1347.
-
Colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) and carbapenem-resistant Enterobacterales (CRE) in healthcare and community settings in Botswana: an antibiotic resistance in communities and hospitals (ARCH) study. Int J Infect Dis. 2022 Sep; 122:313-320.
-
Risk of community- and hospital-acquired bacteremia and profile of antibiotic resistance in children hospitalized with severe acute malnutrition in Niger. Int J Infect Dis. 2022 Jun; 119:163-171.
-
Structural and molecular rationale for the diversification of resistance mediated by the Antibiotic_NAT family. Commun Biol. 2022 03 25; 5(1):263.
-
Rapid expansion and extinction of antibiotic resistance mutations during treatment of acute bacterial respiratory infections. Nat Commun. 2022 03 09; 13(1):1231.
-
Antimicrobial blue light: A 'Magic Bullet' for the 21st century and beyond? Adv Drug Deliv Rev. 2022 01; 180:114057.
-
Prevalence, Costs, and Consequences of Low-Value Preprocedural Urinalyses in the US. JAMA Intern Med. 2021 11 01; 181(11):1533-1535.
-
Antibiotic resistance in dermatology: The scope of the problem and strategies to address it. J Am Acad Dermatol. 2022 06; 86(6):1337-1345.
-
Effects of antibiotic resistance, drug target attainment, bacterial pathogenicity and virulence, and antibiotic access and affordability on outcomes in neonatal sepsis: an international microbiology and drug evaluation prospective substudy (BARNARDS). Lancet Infect Dis. 2021 12; 21(12):1677-1688.